Logo

Cancellation of GE/Abbott Dx Deal Topped Most-Read GenomeWeb Daily News Stories Last Week

Jul 16, 2007
NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, July 13.
 
1. GE Healthcare and Abbott Scuttle $8B Deal for Diagnostics Units (from July 12)
 
2. Despite Looming NIH Cash Crunch, Genomic Nonprofit CEOs Enjoy Soaring Salaries (from July 10)
 
3. Roche Acquires Alnylam Lab to Build RNAi Excellence Center; Buys Stake and Forges Alliance (from July 9)
 
4. Roche, Hungry for Ventana, Challenges State Law; Plans to Pursue Shareholders (from July 11)
 
5. GE Healthcare's Q2 Revenue, Profit Slide (from July 13)
Breaking News
The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.